SkinVision

Founded in 2011, SkinVision BV is headquartered in Amsterdam, Netherlands, and focuses on skin cancer detection through its mobile app.SkinVision offers a mobile application specifically designed for skin cancer detection, leveraging advanced artificial intelligence technology and the expertise of dermatology professionals. The app enables users to conduct self-examinations of their skin by allowing them to take photographs of moles or skin spots, which are then analyzed by the app's algorithm. This service aims to resolve critical user concerns about skin health by providing insights into potential skin cancer risks and suggesting actions for follow-up. The app is particularly beneficial for individuals who spend significant time outdoors, as it emphasizes the importance of regular skin checks due to the high correlation between UV radiation exposure and skin cancer.The revenue model for SkinVision is primarily based on subscription services, where users pay for access to the app's features, which include skin health assessment and personalized recommendations. Users can choose from various pricing plans that may include monthly or yearly subscription options, granting them the ability to perform multiple skin checks and access expert advice. Through direct-to-consumer transactions, the app facilitates a streamlined experience for users, allowing them to manage their skin health effectively. The company aims to expand its market presence by targeting additional regions across Europe and beyond, focusing on countries with high incidences of skin cancer. These initiatives underscore SkinVision's commitment to improving skin health surveillance and increasing user engagement.

1. Series B

   Jul 30, 2018

   Amount

   $7.6M

   Investors

   Locked

2. Series A

   Aug 23, 2015

   Amount

   $3.4M

   Investors

   Locked